Stay updated on KRAS G12C Inhibitor Clinical Trial
Sign up to get notified when there's something new on the KRAS G12C Inhibitor Clinical Trial page.

Latest updates to the KRAS G12C Inhibitor Clinical Trial page
- ChecktodayChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content.SummaryDifference40%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.3%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
- Check36 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about the HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check43 days agoChange DetectedThe web page has updated its version from v2.16.5 to v2.16.6 and changed the date from 2025-07-11 to 2025-07-15.SummaryDifference0.6%
Stay in the know with updates to KRAS G12C Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KRAS G12C Inhibitor Clinical Trial page.